Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1005

1.

Fluvoxamine maleate in the treatment of depression: a single-center, double-blind, placebo-controlled comparison with imipramine in outpatients.

Claghorn JL, Earl CQ, Walczak DD, Stoner KA, Wong LF, Kanter D, Houser VP.

J Clin Psychopharmacol. 1996 Apr;16(2):113-20.

PMID:
8690826
2.

Fluvoxamine versus imipramine and placebo: a double-blind comparison in depressed patients.

Fabre L, Birkhimer LJ, Zaborny BA, Wong LF, Kapik BM.

Int Clin Psychopharmacol. 1996 Jun;11(2):119-27.

PMID:
8803649
3.

Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.

Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.

Eur Neuropsychopharmacol. 2004 Dec;14(6):457-70.

PMID:
15589385
4.

Antidepressant efficacy in relation to item analysis and severity of depression: a placebo-controlled trial of fluvoxamine versus imipramine.

Kasper S, Möller HJ, Montgomery SA, Zondag E.

Int Clin Psychopharmacol. 1995 Jan;9 Suppl 4:3-12.

PMID:
7622821
5.

Effects of imipramine, fluvoxamine and depressive mood on autonomic cardiac functioning in major depressive disorder.

Volkers AC, Tulen JH, van den Broek WW, Bruyn JA, Passchier J, Pepplinkhuizen L.

Pharmacopsychiatry. 2004 Jan;37(1):18-25.

PMID:
14750044
6.
7.

Responders to antidepressant drug treatment: a study comparing nefazodone, imipramine, and placebo in patients with major depression.

Cohn CK, Robinson DS, Roberts DL, Schwiderski UE, O'Brien K, Ieni JR.

J Clin Psychiatry. 1996;57 Suppl 2:15-8.

PMID:
8626358
8.

Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.

Trivedi MH, Pigotti TA, Perera P, Dillingham KE, Carfagno ML, Pitts CD.

J Clin Psychiatry. 2004 Oct;65(10):1356-64.

PMID:
15491239
9.

A comparative study of the efficacy and safety profiles between fluvoxamine and nortriptyline in Japanese patients with major depression.

Otsubo T, Akimoto Y, Yamada H, Koda R, Aoyama H, Tanaka K, Mimura M, Nakagome K, Kamijima K.

Pharmacopsychiatry. 2005 Jan;38(1):30-5.

PMID:
15706464
10.

A double-blind comparison of nefazodone, imipramine, and placebo in major depression.

Fontaine R, Ontiveros A, Elie R, Kensler TT, Roberts DL, Kaplita S, Ecker JA, Faludi G.

J Clin Psychiatry. 1994 Jun;55(6):234-41.

PMID:
8071277
11.

A double-blind comparison of Org 3770, amitriptyline, and placebo in major depression.

Bremner JD.

J Clin Psychiatry. 1995 Nov;56(11):519-25.

PMID:
7592505
13.

A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.

Dominguez RA, Goldstein BJ, Jacobson AF, Steinbook RM.

J Clin Psychiatry. 1985 Mar;46(3):84-7.

PMID:
3918993
14.
15.

Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.

Wohlreich MM, Mallinckrodt CH, Prakash A, Watkin JG, Carter WP.

Depress Anxiety. 2007;24(1):41-52.

PMID:
16845641
16.

Comparison of fluvoxamine, imipramine, and placebo in the treatment of outpatients with panic disorder.

Nair NP, Bakish D, Saxena B, Amin M, Schwartz G, West TE.

Anxiety. 1996;2(4):192-8.

PMID:
9160622
17.

Buspirone and imipramine for the treatment of major depression in the elderly.

Schweizer E, Rickels K, Hassman H, Garcia-España F.

J Clin Psychiatry. 1998 Apr;59(4):175-83.

PMID:
9590668
18.

Fluvoxamine and imipramine in the treatment of depressive patients: a double-blind controlled study.

Gonella G, Baignoli G, Ecari U.

Curr Med Res Opin. 1990;12(3):177-84.

PMID:
2125547
19.

A comparison of fluvoxamine and fluoxetine in the treatment of major depression.

Rapaport M, Coccaro E, Sheline Y, Perse T, Holland P, Fabre L, Bradford D.

J Clin Psychopharmacol. 1996 Oct;16(5):373-8.

PMID:
8889909
20.

A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia.

Thase ME, Fava M, Halbreich U, Kocsis JH, Koran L, Davidson J, Rosenbaum J, Harrison W.

Arch Gen Psychiatry. 1996 Sep;53(9):777-84.

PMID:
8792754

Supplemental Content

Support Center